Susquehanna International Group
PRPH

Susquehanna International Group’s ProPhase Labs PRPH Stock Holding History

Susquehanna International Group’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,940
Closed -$187K – 13278
2022
Q4 		$187K Buy
1,940
+870
+81% +$94K ﹤0.01% 10235
2022
Q3 		$121K Sell
1,070
-640
-37% -$74.5K ﹤0.01% 11509
2022
Q2 		$217K Buy
+1,710
New +$150K ﹤0.01% 10440
2022
Q1 		– Sell
-2,210
Closed -$158K – 13768
2021
Q4 		$158K Buy
2,210
+240
+12% +$14.9K ﹤0.01% 11730
2021
Q3 		$102K Buy
1,970
+870
+79% +$51.8K ﹤0.01% 12062
2021
Q2 		$68K Sell
1,100
-670
-38% -$37.6K ﹤0.01% 12230
2021
Q1 		$131K Buy
+1,770
New +$170K ﹤0.01% 11729

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Susquehanna International Group's PRPH Position: Q4 2025 in Review

Susquehanna International Group sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 39,791 shares — an estimated $182K sold.

Susquehanna International Group first reported a position in PRPH in Q3 2018 and held it in 20 quarters. The position peaked at $446K in Q4 2022. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

  • Susquehanna International Group reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 39,791 ProPhase Labs shares in Q4 2025, an estimated $182K.
  • Susquehanna International Group first reported a position in ProPhase Labs in Q3 2018 and held it in 20 quarters.
  • Susquehanna International Group's ProPhase Labs position peaked at $446K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.